Literature DB >> 22699445

New insights into rotavirus vaccines.

Chiara Mameli1, Valentina Fabiano, Gian Vincenzo Zuccotti.   

Abstract

Rotavirus vaccines have shown to be effective and well tolerated in clinical trials. However it's crucial to point out that immunization occurs in "real-word" conditions different from ideal clinical trial settings. Thus, the impact of rotavirus vaccines in terms of effectiveness and safety needs to be evaluated in real-world conditions. Post-licensure data regarding vaccine impact, effectiveness and safety under routine use are now available and provide a "real-world view". We reviewed published data about the impact of rotavirus vaccines in the post-licensure era.

Mesh:

Substances:

Year:  2012        PMID: 22699445      PMCID: PMC3551871          DOI: 10.4161/hv.20295

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  70 in total

1.  Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.

Authors:  Jim P Buttery; Stephen B Lambert; Keith Grimwood; Michael D Nissen; Emma J Field; Kristine K Macartney; Jonathan D Akikusa; Julian J Kelly; Carl D Kirkwood
Journal:  Pediatr Infect Dis J       Date:  2011-01       Impact factor: 2.129

2.  Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants.

Authors:  Irene M Shui; James Baggs; Manish Patel; Umesh D Parashar; Melisa Rett; Edward A Belongia; Simon J Hambidge; Jason M Glanz; Nicola P Klein; Eric Weintraub
Journal:  JAMA       Date:  2012-02-08       Impact factor: 56.272

Review 3.  Summary of effectiveness and impact of rotavirus vaccination with the oral pentavalent rotavirus vaccine: a systematic review of the experience in industrialized countries.

Authors:  Carlo Giaquinto; Geraldine Dominiak-Felden; Pierre Van Damme; Tin Tin Htar Myint; Yvonne A Maldonado; Vana Spoulou; T Christopher Mast; Mary Allen Staat
Journal:  Hum Vaccin       Date:  2011-07-01

4.  Rotavirus vaccination in Germany: analysis of nationwide surveillance data 2006 to 2010.

Authors:  Ulrike Uhlig; Karel Kostev; Volker Schuster; Holm H Uhlig
Journal:  Pediatr Infect Dis J       Date:  2011-12       Impact factor: 2.129

Review 5.  2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis.

Authors:  Jacqueline E Tate; Anthony H Burton; Cynthia Boschi-Pinto; A Duncan Steele; Jazmin Duque; Umesh D Parashar
Journal:  Lancet Infect Dis       Date:  2011-10-24       Impact factor: 25.071

6.  Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States.

Authors:  Ben A Lopman; Aaron T Curns; Catherine Yen; Umesh D Parashar
Journal:  J Infect Dis       Date:  2011-08-29       Impact factor: 5.226

7.  Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria.

Authors:  Maria Paulke-Korinek; Michael Kundi; Pamela Rendi-Wagner; Alfred de Martin; Gerald Eder; Birgit Schmidle-Loss; Andreas Vecsei; Herwig Kollaritsch
Journal:  Vaccine       Date:  2011-02-12       Impact factor: 3.641

8.  First reports of human rotavirus G8P[4] gastroenteritis in the United States.

Authors:  Geoffrey A Weinberg; Daniel C Payne; Elizabeth N Teel; Slavica Mijatovic-Rustempasic; Michael D Bowen; Mary Wikswo; Jon R Gentsch; Umesh D Parashar
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

9.  Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States.

Authors:  Julie A Boom; Jacqueline E Tate; Leila C Sahni; Marcia A Rench; Jennifer J Hull; Jon R Gentsch; Manish M Patel; Carol J Baker; Umesh D Parashar
Journal:  Pediatrics       Date:  2010-01-18       Impact factor: 7.124

Review 10.  Vaccine herd effect.

Authors:  Tae Hyong Kim; Jennie Johnstone; Mark Loeb
Journal:  Scand J Infect Dis       Date:  2011-05-23
View more
  4 in total

1.  High-Pressure Inactivation of Rotaviruses: Role of Treatment Temperature and Strain Diversity in Virus Inactivation.

Authors:  Elbashir Araud; Erin DiCaprio; Zhihong Yang; Xinhui Li; Fangfei Lou; John H Hughes; Haiqiang Chen; Jianrong Li
Journal:  Appl Environ Microbiol       Date:  2015-07-17       Impact factor: 4.792

2.  Impact of vaccination uptake on hospitalizations due to rotavirus acute gastroenteritis in 2 different socioeconomic areas of Spain.

Authors:  Francisco Giménez Sánchez; Esperanza Jiménez Nogueira; Miguel Sánchez Forte; Mercedes Ibáñez Alcalde; Elvira Cobo; Raquel Angulo; Pablo Garrido Fernández
Journal:  Hum Vaccin Immunother       Date:  2016-04-02       Impact factor: 3.452

3.  Comparative analysis of the immunogenicity of monovalent and multivalent rotavirus immunogens.

Authors:  Kai Mi; Xia Ou; Lili Guo; Jing Ye; Jinyuan Wu; Shan Yi; Xianglian Niu; Xiaoqin Sun; Hongjun Li; Maosheng Sun
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

4.  In vitro Antiviral Activity of Rubia cordifolia Aerial Part Extract against Rotavirus.

Authors:  Yuanyuan Sun; Xuepeng Gong; Jia Y Tan; Lifeng Kang; Dongyan Li; Jihong Yang; Guang Du
Journal:  Front Pharmacol       Date:  2016-09-13       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.